Through Co-immunoprecipitations (Co-IP) assay, we demonstrated that METTL16 specifically interacted with eIF3a and eIF3b, but not other eIF factors in HCC cells (Fig. 4B). Here, EIF3A is linked to hepatocellular carcinoma.